Otsuka’s kidney disease drug shows over 50% reduction in protein in urine
By Thomson ReutersJun 6, 2025 | 5:15 AM
(Reuters) -Otsuka’s drug for a type of kidney disease showed over 50% reduction in protein in patient’s urine in a late-stage trial, the Japan-based company said on Friday.
(Reporting by Sriparna Roy in Bengaluru)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.
